Blocking intracellular degradation of the erythropoietin and asialoglycoprotein receptors by calpain inhibitors does not result in the same increase in the levels of their membrane and secreted forms.
about
Soluble erythropoietin receptor contributes to erythropoietin resistance in end-stage renal diseaseJak3-independent trafficking of the common gamma chain receptor subunit: chaperone function of Jaks revisited.An extracellular region of the erythropoietin receptor of the subterranean blind mole rat Spalax enhances receptor maturation.Endoplasmic reticulum quality control of asialoglycoprotein receptor H2a involves a determinant for retention and not retrieval.Erythropoietin improves motor and cognitive deficit, axonal pathology, and neuroinflammation in a combined model of diffuse traumatic brain injury and hypoxia, in association with upregulation of the erythropoietin receptor.A novel quality control compartment derived from the endoplasmic reticulumConstruction of a fluorescein-responsive chimeric receptor with strict ligand dependency.Amino acid residues 268-276 of the erythropoietin receptor contain an endocytosis motif and are required for erythropoietin-mediated proliferation.A cytosolic domain of the erythropoietin receptor contributes to endoplasmic reticulum-associated degradation.Identification of a cytoplasmic motif in the erythropoietin receptor required for receptor internalization.Folding and self-assembly do not prevent ER retention and proteasomal degradation of asialoglycoprotein receptor H2a.Geldanamycin-associated inhibition of intracellular trafficking is attributed to a co-purified activity.Erythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeability.Upregulation of erythropoietin receptor during postnatal and postpneumonectomy lung growth.
P2860
Q33532601-14D26FC0-35CE-4B02-BA20-A0580D0D1A9FQ34181570-5B1450D5-04B0-4F67-8983-7F27041F0E84Q35971688-B5D4D9CE-F688-4785-A39C-4B767AA06AFBQ36594251-95310C72-7802-4E9E-9F12-555BED34DBAFQ37496924-8FA510C2-3A96-4B9C-AB7A-E3CD0B182C2CQ38761990-C510C4A8-1F3F-44E7-9703-4BBC1225D0AAQ39979097-6AB395E4-A64D-4A43-8F42-BFBD95CE7671Q40733618-405FA5D8-DDEC-40CF-8C1C-1BCB510AFD28Q40941866-7CA3D01C-836E-4A38-B8E2-8703B1FC89FFQ41038414-99021023-5EE1-42B4-93F9-A578315FFCA1Q42808377-FC7F2975-98E8-474C-BAAE-CFC77382012EQ44683493-96290A1D-51A6-4B4D-BBF7-9C0875C7F875Q48144017-63994DBA-A8ED-4348-89B2-9F155E7DCC74Q52088335-D381731C-894A-4C5E-A32A-563C5F3C1B57
P2860
Blocking intracellular degradation of the erythropoietin and asialoglycoprotein receptors by calpain inhibitors does not result in the same increase in the levels of their membrane and secreted forms.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Blocking intracellular degrada ...... r membrane and secreted forms.
@en
type
label
Blocking intracellular degrada ...... r membrane and secreted forms.
@en
prefLabel
Blocking intracellular degrada ...... r membrane and secreted forms.
@en
P2093
P2860
P356
P1433
P1476
Blocking intracellular degrada ...... r membrane and secreted forms.
@en
P2093
P2860
P304
P356
10.1042/BJ3130391
P407
P478
313 ( Pt 2)
P577
1996-01-01T00:00:00Z